Skip to main content

Table 2 Distribution of PN and its association with health status characteristics of the participants

From: Prevalence of peripheral neuropathy and its associated demographic and health status characteristics, among people on antiretroviral therapy in Rwanda

  

PN n (%) n = 507

  

Variable

No PN

PN

p-value

All

CD4 cell count

<=350

63 (51)

91 (49)

0.98

154 (30)

 

>350

144 (41)

209 (59)

353 (70)

Duration since HIV diagnosis

0 – 3 years ago

72 (46)

84 (54)

<0.001*

156 (31)

4 – 6 years ago

91 (49)

96 (51)

187 (37)

 

7 and above yrs

44 (27)

120 (73)

164 (32)

Current ARV regimen

Non d4T containing

156 (39)

247 (61)

0.056

403 (79)

d4T containing

51 (49)

53 (51)

104 (21)

Duration on ARVs (in years)

0 – 1

71 (58)

52 (42)

<0.001*

123 (24)

1 – 3

58 (36)

101 (64)

159 (32)

4 – 6

61 (30)

108 (64)

169 (33)

7 and above

17 (41)

39 (70)

56 (11)

ARV regimen changes

None

44 (43)

48 (57)

0.045

102 (20)

Once

120 (44)

150 (56)

270 (53)

 

Two and more

43 (32)

92 (68)

135 (27)

ARV started with

Non D4T containing

62 (37)

104 (63)

0.27

166 (33)

 

D4T containing

145 (43)

196 (57)

341 (67)

  1. *Denotes significant association, n = number of participants.